Our scientists, during
the last decade, utilizing extensive experience in structural studies and recombinant production of plasma proteins, have developed the proprietary albumin-based drug development platform CADEX™.
 |
Cadex™
The CADEX™ (Crystallography and Albumin-based Drug Design and Evaluation) platform
is a comprehensive library of atomic structures of the binding characteristics of drugs with human serum albumin and other key blood proteins spanning over 25 therapeutic categories summarized in the table below.
Theraputic Categories of Structures Solved by Cadex™
- Analgesics
- Anti-arrhythmic
- Anti-cancer
- Anti-depressant
- Anti-hypersensitive
- Anti-Porphyria
- Anxiolitic
- Diagnostics
- NSAIDs
|
- Anesthetics
- Anti-asthma
- Anti-coagulant
- Anti-diabetic
- Anti-infective
- Anti-psychotic
- Calcium blockers
- Hormone replacement
|
- Anti-amyotrophic
- Anti-bacterial
- Anti-convulsants
- Anti-histamine
- Anti-inflammatory
- Anti-ulcerative
- Cholesterol lowering
- Muscle relaxants
|
|
